BIONX quote
8.36up +0.04 +0.48%
Previous Close8.32CategoryLarge Growth
Net Assets53.06 MilDividend Yield0.00%
Morningstar ratings:Minimum Initial Purchase1,000
RiskAverage1 Year Return34.63%
RatingRating: 2 out of 53 Year Return-6.68%
ReturnBelow Average5 Year ReturnNA
Cumulative growth of a $10,000 investment
10k growth chart
200720082009YTD
Growth11.83%1.54%-25.99%-14.45%
Value$11,183$10,154$7,401$8,555
Last NAV update 6:25 PM ET   Financial data in U.S. dollars

Your latest quotes:  DUK, CTL, SWHC, BIONX, NWN, ECIFF

Overview
The investment seeks capital appreciation. The fund primarily invests in a diversified portfolio of equity securities of companies that above-average future growth potential relative to their peers. It invests in companies of all sizes traded on any stock exchange in the United States without regard to the market capitalization. The fund normally invests in domestic companies, but also may invest in securities of foreign issuers. The fund may invest up to 20% of total assets in fixed-income or debt securities with a minimum credit quality of investment-grade. It typically holds 20 to 50 equity investments. The fund is nondiversified.
More information for BIONX
Fees and expenses
Front load0.00%
Deferred load0.00%
Expense Ratio1.50%
Top holdings for BIONX
Company Name% Net Assets
Intuitive Surgical, Inc.8.26%
J.P. Morgan Chase & Co.5.32%
Apple, Inc.4.82%
Qualcomm, Inc.4.31%
Genzyme Corporation4.08%
More top holdings for BIONX
Additional Fund Information
Inception date05/03/2006
ManagerJoseph Biondo
Manager start date05/03/2006
advertisement
Market update 3:46pm ET

7 things to ask before buying a stock

Putting your money in the market can leave you open to some nasty surprises. Avoid them by doing the right research.

More market news
advertisement


Page generated 6:46 PM Eastern Time